Company news
Scopus BioPharma, Inc. news in 2023
Scopus BioPharma, Inc.'s news releases, calls and decks from 2023, newest first.
Scopus BioPharma’s Subsidiary — Duet BioTherapeutics — Presents Compelling New Data for a Novel Treatment for Malignant Glioma at 38th Annual Meeting of the Society for Immunotherapy of Cancer
November 6, 2023
Scopus BioPharma’s Subsidiary — Duet BioTherapeutics — to Present at the 38th Annual Meeting of the Society for Immunotherapy of Cancer
November 1, 2023